Quest Diagnostics (DGX) Total Current Liabilities (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Total Current Liabilities data on file, last reported at $2.2 billion in Q1 2026.

• Quarterly Total Current Liabilities rose 51.08% year-over-year to $2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 51.08% YoY) and the FY2025 annual result came in at $2.3 billion, up 5.03% from the prior year.
• Total Current Liabilities declined to $2.2 billion in Q1 2026 per DGX's latest filing, from $2.3 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $2.3 billion in Q1 2024, with the low at $1.4 billion in Q1 2023.
• Average Total Current Liabilities over 5 years is $1.9 billion, with a median of $1.9 billion recorded in 2023.
• Year-over-year, Total Current Liabilities soared 69.59% in 2024 and plunged 37.29% in 2025.
• Quest Diagnostics' Total Current Liabilities stood at $1.6 billion in 2022, then gained by 17.02% to $1.8 billion in 2023, then climbed by 19.5% to $2.2 billion in 2024, then advanced by 5.03% to $2.3 billion in 2025, then slipped by 4.43% to $2.2 billion in 2026.
• Business Quant data shows DGX's Total Current Liabilities at $2.2 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.1 billion in Q3 2025.